And if you're willing to play the game of comparing different trials then perhaps you should look at the recent Eyelea 8mg extended dosing schedule, the one the FDA knocked back.
Take a look at the published results and compare that to the Opthea phase 2 trial. Interesting.
- Forums
- ASX - By Stock
- Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
And if you're willing to play the game of comparing different...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
41.0¢ |
Change
0.005(1.23%) |
Mkt cap ! $504.7M |
Open | High | Low | Value | Volume |
41.5¢ | 42.0¢ | 40.0¢ | $458.6K | 1.119M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 298731 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.5¢ | 49490 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 266550 | 0.410 |
8 | 176806 | 0.405 |
11 | 205071 | 0.400 |
8 | 205711 | 0.395 |
9 | 140810 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.415 | 49490 | 1 |
0.420 | 181330 | 5 |
0.425 | 20000 | 1 |
0.440 | 13031 | 2 |
0.445 | 1 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |